{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:44:29Z","timestamp":1791837869121,"version":"4.3.4"},"reference-count":4,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Can J Emerg Med"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s43678-026-01278-0","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:45:14Z","timestamp":1791834314000},"page":"891-892","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fibrinogen in trauma patients: finding the needle or shrinking the haystack?"],"prefix":"10.1007","volume":"28","author":[{"given":"Andrew","family":"Petrosoniak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannie","family":"Callum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"key":"1278_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s43678-026-01217-z","author":"F Al-Haimus","year":"2023","unstructured":"Al-Haimus, F., Ghamarian, E., Nisenbaum, R, et al. Clinical and physiologic factors associated with early hypofibrinogenemia in trauma. Can J Emerg Med (2026). https:\/\/doi.org\/10.1007\/s43678-026-01217-z","journal-title":"Can J Emerg Med"},{"issue":"19","key":"1278_CR2","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1001\/jama.2023.21019","volume":"330","author":"R Davenport","year":"2023","unstructured":"Davenport R, et al. Early and empirical high-dose cryoprecipitate for hemorrhage after traumatic injury: the CRYOSTAT-2 randomized clinical trial. JAMA. 2023;330(19):1882\u201391.","journal-title":"JAMA"},{"issue":"12","key":"1278_CR3","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1111\/j.1537-2995.2010.02934.x","volume":"50","author":"JL Callum","year":"2010","unstructured":"Callum JL, et al. Rapid laboratory testing for trauma patients: where a perfect result may not be in the best interests of the patient. Transfusion. 2010;50(12):2529\u201332.","journal-title":"Transfusion"},{"key":"1278_CR4","unstructured":"Massive Hemorrhage Protocol. Provincial recommendation statements, version 2.0, March 2025. Ontario Regional Blood Coordinating Network. https:\/\/transfusionontario.org\/en\/massive-hemorrhage-protocol\/. Accessed 27 Aug 2026."}],"container-title":["Canadian Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43678-026-01278-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43678-026-01278-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43678-026-01278-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:45:15Z","timestamp":1791834315000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43678-026-01278-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":4,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1278"],"URL":"https:\/\/doi.org\/10.1007\/s43678-026-01278-0","relation":{},"ISSN":["1481-8035","1481-8043"],"issn-type":[{"value":"1481-8035","type":"print"},{"value":"1481-8043","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"12 October 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Petrosoniak has received speaking honoaria from Octapharma and Aerogen. Dr. Callum has received research funding from Canadian Blood Services and Octapharma, and consulting fees and honoraria from Octapharma.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}